drugset / Trial / NCT00853944

Effect of Sitagliptin on Graft Function Following Islet Transplantation

NCT00853944

RandomizedSingle-groupDouble-blindTreatment

Summary

Islet transplantation requires a large number of islets required to achieve insulin independence and the function of the transplanted islets progressively declines over time. Evidence from animal studies and human islets in culture suggests that increasing GLP-1 levels could help with both of these problems. This study is designed to test this hypothesis using sitagliptin in a randomized clinical trial.

Timeline

Start
2009-07
Primary completion
2013-11-01
Completion
2013-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sitagliptin Small molecule 100 mg Oral

Indications

No indication recorded.